PLoS ONE (Jan 2013)

Cerebral ischemia is exacerbated by extracellular nicotinamide phosphoribosyltransferase via a non-enzymatic mechanism.

  • Bing Zhao,
  • Meng Zhang,
  • Xue Han,
  • Xia-Yan Zhang,
  • Qiong Xing,
  • Xu Dong,
  • Qiao-Juan Shi,
  • Peng Huang,
  • Yun-Bi Lu,
  • Er-Qing Wei,
  • Qiang Xia,
  • Wei-Ping Zhang,
  • Chun Tang

DOI
https://doi.org/10.1371/journal.pone.0085403
Journal volume & issue
Vol. 8, no. 12
p. e85403

Abstract

Read online

Intracellular nicotinamide phosphoribosyltransferase (iNAMPT) in neuron has been known as a protective factor against cerebral ischemia through its enzymatic activity, but the role of central extracellular NAMPT (eNAMPT) is not clear. Here we show that eNAMPT protein level was elevated in the ischemic rat brain after middle-cerebral-artery occlusion (MCAO) and reperfusion, which can be traced to at least in part from blood circulation. Administration of recombinant NAMPT protein exacerbated MCAO-induced neuronal injury in rat brain, while exacerbated oxygen-glucose-deprivation (OGD) induced neuronal injury only in neuron-glial mixed culture, but not in neuron culture. In the mixed culture, NAMPT protein promoted TNF-α release in a time- and concentration-dependent fashion, while TNF-α neutralizing antibody protected OGD-induced, NAMPT-enhanced neuronal injury. Importantly, H247A mutant of NAMPT with essentially no enzymatic activity exerted similar effects on ischemic neuronal injury and TNF-α release as the wild type protein. Thus, eNAMPT is an injurious and inflammatory factor in cerebral ischemia and aggravates ischemic neuronal injury by triggering TNF-α release from glia cells, via a mechanism not related to NAMPT enzymatic activity.